{"entity":{"id":"journal-of-nuclear-medicine","kind":"journal","name":"Journal of Nuclear Medicine","aka":["JNM","J Nucl Med"],"tldr":"The Journal of Nuclear Medicine is the SNMMI's journal and the core venue for PET tracers and radioligand therapy: PSMA and somatostatin imaging, lutetium and actinium dosimetry, and theranostics trials.","summary":"The Journal of Nuclear Medicine appears monthly and publishes first-in-human tracer studies, PSMA PET diagnostic accuracy trials, radioligand-therapy dosimetry and outcomes (lutetium-177 PSMA and DOTATATE, actinium-225), and SNMMI procedure standards. Articles become free to read after a delay; the SNMMI annual meeting abstracts are published as a supplement.","asOf":"2026-09-09","links":[{"label":"SNMMI","url":"https://www.snmmi.org"}],"tags":[],"related":["src-snmmi"],"cancers":[],"sections":[],"technologies":["radioligand-therapy"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"Society of Nuclear Medicine and Molecular Imaging","url":"https://jnm.snmjournals.org","issn":"0161-5505","scope":"nuclear medicine","access":"hybrid","founded":1960,"matchNames":["Journal of Nuclear Medicine","JNM","J Nucl Med","The Journal of Nuclear Medicine"],"society":"Society of Nuclear Medicine and Molecular Imaging"},"route":"/journals/journal-of-nuclear-medicine/","neighbours":{"collection":[{"id":"src-snmmi","kind":"collection","name":"SNMMI Annual Meeting","route":"/collections/src-snmmi/"}],"technology":[{"id":"radioligand-therapy","kind":"technology","name":"Radioligand therapy (beta emitters)","route":"/technologies/radioligand-therapy/"}],"person":[{"id":"clemens-kratochwil","kind":"person","name":"Clemens Kratochwil","route":"/people/clemens-kratochwil/"},{"id":"frederik-giesel","kind":"person","name":"Frederik Giesel","route":"/people/frederik-giesel/"},{"id":"jason-lewis","kind":"person","name":"Jason S. Lewis","route":"/people/jason-lewis/"},{"id":"jeremie-calais","kind":"person","name":"Jeremie Calais","route":"/people/jeremie-calais/"},{"id":"uwe-haberkorn","kind":"person","name":"Uwe Haberkorn","route":"/people/uwe-haberkorn/"}],"paper":[{"id":"paper-kratochwil-j-nucl-med","kind":"paper","name":"68 Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer","route":"/key-papers/paper-kratochwil-j-nucl-med/"},{"id":"paper-pandit-taskar-j-nucl-med","kind":"paper","name":"Biodistribution and Dosimetry of 18 F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies","route":"/key-papers/paper-pandit-taskar-j-nucl-med/"},{"id":"paper-farwell-j-nucl-med","kind":"paper","name":"CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89 Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody","route":"/key-papers/paper-farwell-j-nucl-med/"},{"id":"paper-pryma-high-specific-activity-i131-mibg-ppgl-jnm-2019","kind":"paper","name":"Efficacy and safety of high-specific-activity 131I-MIBG therapy in advanced pheochromocytoma or paraganglioma","route":"/key-papers/paper-pryma-high-specific-activity-i131-mibg-ppgl-jnm-2019/"},{"id":"paper-badawi-j-nucl-med","kind":"paper","name":"First Human Imaging Studies with the EXPLORER Total-Body PET Scanner","route":"/key-papers/paper-badawi-j-nucl-med/"},{"id":"paper-nct05413850-j-nucl-med-2024","kind":"paper","name":"First Safety and Efficacy Data with the Radiohybrid 177 Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer","route":"/key-papers/paper-nct05413850-j-nucl-med-2024/"}]}}